{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T09:48:34Z","timestamp":1792489714782,"version":"4.5.0"},"reference-count":67,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,8,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Unplanned radiation treatment breaks and prolongation of the radiation treatment time are associated with lower survival and locoregional control rates when radiotherapy or concurrent chemoradiotherapy is used in the curative treatment of head and neck cancer. Treatment of head and neck cancer is intense, involving high-dose, continuous radiotherapy, and often adding chemotherapy to radiotherapy. As the intensity of treatment regimens has escalated in recent years, clinical outcomes generally have improved. However, more intensive therapy also increases the incidence of treatment-related toxicities, particularly those impacting the mucosal lining of the oral cavity, pharynx, and cervical esophagus, and results in varying degrees of ulcerative mucositis. Ulcerative mucositis is a root cause of unscheduled radiation treatment breaks, which prolongs the total radiation treatment time. Alterations in radiotherapy and chemotherapy, including the use of continuous (i.e., 7 days\/week) radiotherapy to ensure constant negative proliferative pressure, may improve efficacy outcomes. However, these approaches also increase the incidence of ulcerative mucositis, thereby increasing the incidence of unplanned radiation treatment breaks. Conversely, the reduction of ulcerative mucositis to minimize unplanned breaks in radiotherapy may enhance not only tolerability, but also efficacy outcomes. Several strategies to prevent ulcerative mucositis in radiotherapy for head and neck cancer have been evaluated, but none have demonstrated strong efficacy. Continued investigation is needed to identify superior radiation treatment regimens, technology, and supportive care that reduce unplanned radiation treatment breaks with the goal of improving clinical outcomes in head and neck cancer.<\/jats:p>","DOI":"10.1634\/theoncologist.2008-0024","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T01:45:15Z","timestamp":1218678315000},"page":"886-898","source":"Crossref","is-referenced-by-count":177,"title":["Radiation Treatment Breaks and Ulcerative Mucositis in Head and Neck Cancer"],"prefix":"10.1093","volume":"13","author":[{"given":"Gregory","family":"Russo","sequence":"first","affiliation":[{"name":"a Department of Radiation Oncology, Jefferson Medical College, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Haddad","sequence":"additional","affiliation":[{"name":"b Department of Medical Oncology, Dana-Farber Cancer Institute\/Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marshall","family":"Posner","sequence":"additional","affiliation":[{"name":"b Department of Medical Oncology, Dana-Farber Cancer Institute\/Harvard Medical School, Boston, Massachusetts, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Machtay","sequence":"additional","affiliation":[{"name":"a Department of Radiation Oncology, Jefferson Medical College, Philadelphia, Pennsylvania, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2008,8,13]]},"reference":[{"key":"2021122208574153400_R1","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics, 2007","volume":"57","author":"Jemal","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"2021122208574153400_R2","volume-title":"Surveillance, Epidemiology, and End Results","author":"National Cancer Institute"},{"key":"2021122208574153400_R3","article-title":"The evolution of induction chemotherapy and sequential therapy for locally advanced squamous cell cancer of the head and neck","volume-title":"American Society of Clinical Oncology (ASCO) Educational Book: 42nd ASCO Annual Meeting","author":"Posner","year":"2006"},{"key":"2021122208574153400_R4","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.ijrobp.2007.03.010","article-title":"Effects of prolongation of overall treatment time due to unplanned interruptions during radiotherapy of different tumor sites and practical methods for compensation","volume":"68","author":"Bese","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R5","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/j.ejca.2007.03.022","article-title":"Chemoradiation comparing cisplatin versus carboplatin in locally advanced nasopharyngeal cancer: Randomised, non-inferiority, open trial","volume":"43","author":"Chitapanarux","year":"2007","journal-title":"Eur J Cancer"},{"key":"2021122208574153400_R6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.3109\/02841868809090333","article-title":"The hazard of accelerated tumor clonogen repopulation during radiotherapy","volume":"27","author":"Withers","year":"1988","journal-title":"Acta Oncol"},{"key":"2021122208574153400_R7","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0360-3016(02)02936-X","article-title":"How fast is repopulation of tumor cells during the treatment gap?","volume":"54","author":"Tarnawski","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R8","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1002\/(SICI)1520-6823(1999)7:6<321::AID-ROI2>3.0.CO;2-Q","article-title":"Molecular mechanisms of radiation-induced accelerated repopulation","volume":"7","author":"Schmidt-Ullrich","year":"1999","journal-title":"Radiat Oncol Investig"},{"key":"2021122208574153400_R9","first-page":"545","article-title":"The importance of the timing of a gap in radiotherapy of squamous cell carcinomas of the head and neck","volume":"170","author":"Herrmann","year":"1994","journal-title":"Strahlenther Onkol"},{"key":"2021122208574153400_R10","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0167-8140(98)00038-3","article-title":"Effect of gap length and position on results of treatment of cancer of the larynx in Scotland by radiotherapy: A linear quadratic analysis","volume":"48","author":"Robertson","year":"1998","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R11","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0360-3016(97)00716-5","article-title":"Similar decreases in local tumor control are calculated for treatment protraction and for interruptions in the radiotherapy of carcinoma of the larynx in four centers","volume":"40","author":"Robertson","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0360-3016(02)04469-3","article-title":"Time factor in postoperative radiotherapy: A multivariate locoregional control analysis in 868 patients","volume":"56","author":"Suwinski","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R13","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/j.ijrobp.2005.10.010","article-title":"Compromised local control due to treatment interruptions and late treatment breaks in early glottic cancer: Population-based outcomes study supporting need for intensified treatment schedules","volume":"64","author":"Groome","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R14","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-8140(92)90323-M","article-title":"The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer","volume":"23","author":"Barton","year":"1992","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R15","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0360-3016(92)90768-D","article-title":"Loss of local control with prolongation in radiotherapy","volume":"23","author":"Fowler","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R16","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/0360-3016(95)00228-Q","article-title":"Local control of carcinoma of the tonsil by radiation therapy: An analysis of patterns of fractionation in nine institutions","volume":"33","author":"Withers","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R17","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/radiology.201.3.8939214","article-title":"Elapsed radiation therapy treatment time as a predictor of survival in patients with advanced head and neck cancer who receive chemotherapy and radiation therapy","volume":"201","author":"Alden","year":"1996","journal-title":"Radiology"},{"key":"2021122208574153400_R18","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/hed.10038","article-title":"Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck","volume":"24","author":"Rosenthal","year":"2002","journal-title":"Head Neck"},{"key":"2021122208574153400_R19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0360-3016(97)00152-1","article-title":"An analysis of factors influencing the outcome of postoperative irradiation for squamous cell carcinoma of the oral cavity","volume":"39","author":"Parsons","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0360-3016(01)01690-X","article-title":"Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer","volume":"51","author":"Ang","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R21","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0360-3016(01)02606-2","article-title":"Effect of treatment delay on outcome of patients with early-stage head-and-neck carcinoma receiving radical radiotherapy","volume":"52","author":"Fortin","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R22","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199210153271602","article-title":"Treatment of advanced squamous-cell carcinoma of the head and neck with alternating chemotherapy and radiotherapy","volume":"327","author":"Merlano","year":"1992","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R23","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1093\/jnci\/88.9.583","article-title":"Five-year update of a randomized trial of alternating radiotherapy and chemotherapy compared with radiotherapy alone in treatment of unresectable squamous cell carcinoma of the head and neck","volume":"88","author":"Merlano","year":"1996","journal-title":"J Natl Cancer Inst"},{"key":"2021122208574153400_R24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/0167-8140(92)90242-M","article-title":"Hyperfractionation versus conventional fractionation in oropharyngeal carcinoma: Final analysis of a randomized trial of the EORTC cooperative group of radiotherapy","volume":"25","author":"Horiot","year":"1992","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0360-3016(00)00663-5","article-title":"A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: First report of RTOG 9003","volume":"48","author":"Fu","year":"2000","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R26","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/S0140-6736(03)14361-9","article-title":"Five compared with six fractions per week of conventional radiotherapy of squamous-cell carcinoma of head and neck: DAHANCA 6 and 7 randomised controlled trial","volume":"362","author":"Overgaard","year":"2003","journal-title":"Lancet"},{"key":"2021122208574153400_R27","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/S0167-8140(00)00139-0","article-title":"Randomized clinical trial on 7-day-continuous accelerated irradiation (CAIR) of head and neck cancer\u2014report on 3-year tumour control and normal tissue toxicity","volume":"55","author":"Skladowski","year":"2000","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R28","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.ijrobp.2006.05.026","article-title":"Continuous accelerated 7-days-a-week radiotherapy for head-and-neck cancer: Long-term results of phase III clinical trial","volume":"66","author":"Skladowski","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R29","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(97)00094-7","article-title":"A randomised multicentre trial of CHART versus conventional radiotherapy in head and neck cancer","volume":"44","author":"Dische","year":"1997","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(06)69121-6","article-title":"Hyperfractionated or accelerated radiotherapy in head and neck cancer: A meta-analysis","volume":"368","author":"Bourhis","year":"2006","journal-title":"Lancet"},{"key":"2021122208574153400_R31","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2407-6-28","article-title":"A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck","volume":"6","author":"Budach","year":"2006","journal-title":"BMC Cancer"},{"key":"2021122208574153400_R32","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0167-8140(97)01904-X","article-title":"Importance of overall treatment time for the outcome of radiotherapy of advanced head and neck carcinoma: Dependency on tumor differentiation","volume":"43","author":"Hansen","year":"1997","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R33","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0167-8140(96)01776-8","article-title":"Randomized clinical trial on accelerated 7 days per week fractionation in radiotherapy for head and neck cancer. Preliminary report on acute toxicity","volume":"40","author":"Maciejewski","year":"1996","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R34","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0167-8140(01)00358-9","article-title":"Radiotherapy-related early morbidity in head and neck cancer: Quantitative clinical radiobiology as deduced from the CHART trial","volume":"60","author":"Bentzen","year":"2001","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R35","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R36","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa032641","article-title":"Postoperative irradiation with or without concomitant chemotherapy for locally advanced head and neck cancer","volume":"350","author":"Bernier","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R37","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1056\/NEJM199806183382503","article-title":"Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer","volume":"338","author":"Brizel","year":"1998","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R38","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1093\/jnci\/91.24.2081","article-title":"Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-stage oropharynx carcinoma","volume":"91","author":"Calais","year":"1999","journal-title":"J Natl Cancer Inst"},{"key":"2021122208574153400_R39","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1200\/JCO.2004.08.021","article-title":"Final results of the 94\u201301 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radiotherapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma","volume":"22","author":"Denis","year":"2004","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R40","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1056\/NEJMoa032646","article-title":"Postoperative concurrent radiotherapy and chemotherapy for high-risk squamous-cell carcinoma of the head and neck","volume":"350","author":"Cooper","year":"2004","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R41","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R42","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0360-3016(01)01544-9","article-title":"Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy\u2014results of a multicentric randomized German trial in advanced head-and-neck cancer","volume":"50","author":"Staar","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R43","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S0140-6736(00)90011-4","article-title":"Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data Meta-Analysis of Chemotherapy on Head and Neck Cancer","volume":"355","author":"Pignon","year":"2000","journal-title":"Lancet"},{"issue":"suppl. 3","key":"2021122208574153400_R44","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/S0360-3016(99)90461-3","article-title":"The influence of overall radiation time (ORT) in patients treated with chemoradiotherapy for squamous cancer of the head and neck","volume":"45","author":"Gibbs","year":"1999","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R45","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/0360-3016(93)90006-H","article-title":"A randomized trial of radiation therapy compared to split course radiation therapy combined with mitomycin C and 5 fluorouracil as initial treatment for advanced laryngeal and hypopharyngeal squamous carcinoma","volume":"25","author":"Keane","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R46","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2003.09.081","article-title":"Randomized trial of dose-dense versus conventionally scheduled and sequential versus concurrent combination chemotherapy as postoperative adjuvant treatment of node-positive primary breast cancer: First report of Intergroup Trial C9741\/Cancer and Leukemia Group B Trial 9741","volume":"21","author":"Citron","year":"2003","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R47","article-title":"Five year follow-up of INT C9741: Dose-dense (DD) chemotherapy (CRx) is safe and effective","volume-title":"Presented at the 2005 San Antonio Breast Cancer Symposium","author":"Hudis"},{"key":"2021122208574153400_R48","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1200\/JCO.1990.8.6.963","article-title":"Prognostic significance of actual dose intensity in diffuse large-cell lymphoma: Results of a tree-structured survival analysis","volume":"8","author":"Kwak","year":"1990","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R49","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/0360-3016(94)90238-0","article-title":"Time-dose relationship for local tumor control following alternate week concomitant radiation and chemotherapy of advanced head and neck cancer","volume":"29","author":"Wong","year":"1994","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R50","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1200\/JCO.2006.05.8529","article-title":"High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial","volume":"24","author":"Cohen","year":"2006","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R51","volume-title":"Cetuximab (ERBITUX\u00ae) Added to Two Concurrent Chemoradiotherapy Platforms in Locally Advanced Head and Neck Cancer (EPIC)"},{"key":"2021122208574153400_R52","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-8140(02)00404-8","article-title":"Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: A systematic literature review","volume":"66","author":"Trotti","year":"2003","journal-title":"Radiother Oncol"},{"key":"2021122208574153400_R53","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/cncr.21622","article-title":"Oral mucositis in patients undergoing radiation treatment for head and neck carcinoma","volume":"106","author":"Vera-Llonch","year":"2006","journal-title":"Cancer"},{"key":"2021122208574153400_R54","volume-title":"Erbitux\u00ae (cetuximab) [full prescribing information]","year":"2007"},{"key":"2021122208574153400_R55","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1056\/NEJMoa053422","article-title":"Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck","volume":"354","author":"Bonner","year":"2006","journal-title":"N Engl J Med"},{"key":"2021122208574153400_R56","first-page":"275","article-title":"Is one Gy equal to one Gy after treatment interruptions?","volume":"29","author":"Grillo-Ruggieri","year":"2004","journal-title":"Rays"},{"issue":"2","key":"2021122208574153400_R57","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001973.pub3","article-title":"Interventions for treating oral mucositis for patients with cancer receiving treatment","author":"Clarkson","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"2021122208574153400_R58","article-title":"Interventions for preventing oral mucositis for patients with cancer receiving treatment","author":"Worthington","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"2021122208574153400_R59","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/1097-0142(20010815)92:4<875::AID-CNCR1396>3.0.CO;2-1","article-title":"Benzydamine HCl for prophylaxis of radiation-induced oral mucositis: Results from a multicenter, randomized, double-blind, placebo-controlled clinical trial","volume":"92","author":"Epstein","year":"2001","journal-title":"Cancer"},{"key":"2021122208574153400_R60","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1097\/00002820-200609000-00012","article-title":"A pilot study of chlorhexidine and benzydamine oral rinses for the prevention and treatment of irradiation mucositis in patients with head and neck cancer","volume":"29","author":"Kin-Fong Cheng","year":"2006","journal-title":"Cancer Nurs"},{"key":"2021122208574153400_R61","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/hed.10382","article-title":"Protective effect of alpha-tocopherol in head and neck cancer radiation-induced mucositis: A double-blind randomized trial","volume":"26","author":"Ferreira","year":"2004","journal-title":"Head Neck"},{"key":"2021122208574153400_R62","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1023\/A:1008282412670","article-title":"Selective cytoprotection with amifostine in concurrent radiochemotherapy for head and neck cancer","volume":"9","author":"B\u00fcntzel","year":"1998","journal-title":"Ann Oncol"},{"key":"2021122208574153400_R63","doi-asserted-by":"crossref","first-page":"3339","DOI":"10.1200\/JCO.2000.18.19.3339","article-title":"Phase III randomized trial of amifostine as a radioprotector in head and neck cancer","volume":"18","author":"Brizel","year":"2000","journal-title":"J Clin Oncol"},{"key":"2021122208574153400_R64","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.ijrobp.2005.08.005","article-title":"Intravenous amifostine during chemoradiotherapy for head-and-neck cancer: A randomized placebo-controlled phase III study","volume":"64","author":"Buentzel","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R65","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/S0360-3016(03)01627-4","article-title":"A multinational, randomized phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy","volume":"58","author":"Trotti","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R66","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0360-3016(00)01456-5","article-title":"Prophylaxis of oral mucositis in irradiated head-and-neck cancer patients: A proposed classification scheme of interventions and meta-analysis of randomized controlled trials","volume":"49","author":"Sutherland","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2021122208574153400_R67","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1056\/NEJMoa040125","article-title":"Palifermin for oral mucositis after intensive therapy for hematologic cancers","volume":"351","author":"Spielberger","year":"2004","journal-title":"N Engl J Med"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2008-0024","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2008-0024","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/8\/886\/41832535\/oncolo_13_8_886.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/13\/8\/886\/41832535\/oncolo_13_8_886.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T15:48:49Z","timestamp":1640188129000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/13\/8\/886\/6397470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8,1]]},"references-count":67,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2008,8,13]]},"published-print":{"date-parts":[[2008,8,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2008-0024","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2008,8,1]]},"published":{"date-parts":[[2008,8,1]]}}}